Abstract
Drug-induced autoimmunity encompasses a wide range of serological and clinical manifestations that develop after exposure to a drug. The classical and most studied example is drug-induced lupus (DIL). Although autoimmunity secondary to drugs has been recognized for more than 50 years, the introduction of new drugs has extended the spectrum and severity of clinical manifestations. Several drugs are associated with the induction of antinuclear and anti-DNA antibodies, but clinical lupus is rare, and a number of drugs are associated with antineutrophilic cytoplasmic antibody (ANCA)-positive vasculitis. The diagnosis of these conditions is not simple and requires careful elimination of other possible conditions. Although rare cases of life-threatening autoimmune conditions have been described, the majority of cases are mild and resolve after the offending drug is discontinued.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Yung RL, Richardson BC. Drug-induced lupus. Rheum Dis Clin North Am 1994; 20: 61–86.
Vial T, Nicolas B, Descortes J. Drug-induced autoimmunity: Experience of the French Pharmacovigilance system. Toxicology 1997; 119: 23–7.
Price EJ, Venables PJW. Drug-induced lupus. Drug Saf 1995; 1: 283–90.
Kretz-Rommel A, Rubin RL. Disruption of positive selection of thymocytes causes autoimmunity. Nat Med 2000; 6: 298–305.
Bucy RP, Xu XY, Li J, Huang GO. Cyclosporine A-induced autoimmune disease in mice. J Immunol 1993; 151: 1039–50.
Oelke K, Lu O, Richardson D, Wu A, Deng C, Hanash S, Richardson B. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum 2004; 50: 1850–60.
Pichler WJ. Drug-induced autoimmunity. Curr Opin Allergy Clin Immunol 2003; 3: 249–53.
Rao T, Richardson B. Environmentally induced autoimmune diseases: Potential mechanisms. Environ Health Perspect 1999; 107(Suppl. 5): 737–42.
Uetrecht JP. Idiosyncratic drug-reactions: Current understanding. Annu Rev Pharmacol Toxicol 2007; 47: 13–39.
Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12: 991–1045.
Rubin RL. Drug-induced lupus. Toxicology 2005; 209: 135–47.
Yung R, Richardson B. Drug-induced rheumatic syndromes. Bull Rheum Dis 2002; 51. 1–6.
Elkayam O, Yaron M, Caspi D. Minocycline-induced autoimmune syndromes: An overview. Semin Arthritis Rheum 1999; 28: 392–7.
Aloush V, Litinsky I, Caspi D, Elkayam O. Propylthiouracil-induced autoimmune syndromes: Two distinct clinical presentations with different course and management. Semin Arthritis Rheum 2006; 36: 4–9.
Masi A, Hamilos DL. Leukotriene antagonists: Bystanders or causes of Churg-Strauss syndrome. Semin Arthritis Rheum 2002; 31: 211–7.
Oppenheim Y, Ban Y, Tomer Y. Interferon induced autoimmune thyroid disease (AITD): A model for human autoimmunity. Autoimmun Rev 2004; 3: 388–93.
De Bandt M, Sibilia J, Le Loët X, Prouzeau S, Fautrel B, Marcelli C, Boucquillard E, Siame JL, Mariette X. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: A French national survey. Arthritis Res Ther 2005; 7: R545–51.
De Rycke L, Kruithof E, Van Damme N, Hoffman IE, Van den Bossche N, Van den Bosch F, Veys EM, De Keyser F. Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy. Arthritis Rheum 2003; 48: 1015–23.
Ioannou Y, Isenberg DA. Review: Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum 2000; 43: 1431–41.
Centocor, Inc. Remicade (infliximab). Data on file. Malvern, PA, USA: Centocor, Inc.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Szyper-Kravitz, M., Shoenfeld, Y. (2008). Drug-Induced Autoimmunity. In: Shoenfeld, Y., Cervera, R., Gershwin, M.E. (eds) Diagnostic Criteria in Autoimmune Diseases. Humana Press. https://doi.org/10.1007/978-1-60327-285-8_11
Download citation
DOI: https://doi.org/10.1007/978-1-60327-285-8_11
Publisher Name: Humana Press
Print ISBN: 978-1-60327-427-2
Online ISBN: 978-1-60327-285-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)